Reproductive health

VERACITY is one of the most advanced non-invasive prenatal tests (NIPT).
It is a next-generation test that allows the detection of chromosomal abnormalities in the fetus at an early stage of pregnancy.  

Rodinia is a genetic test that allows the detection of changes in genes associated with infertility in both women and men. The male panel includes the analysis of 40 genes and the evaluation of sex chromosomes X and Y, including Y chromosome microdeletion. The female panel analyzes the full coding sequence of 55 genes and evaluates sex chromosome aneuploidies, including changes in number, structural changes, and mosaicism.

Rodinia is a genetic test that detects changes in genes associated with female infertility. The panel includes 55 genes and sex chromosome aneuploidies, including changes in their number, structure, and mosaicism.

Rodinia test for thrombophilia and neonatal thrombocytopenia (NAIT) detects genetic variants that increase the risk of miscarriages, thrombotic events, and alloimmune neonatal thrombocytopenia (NAIT). 

Rodinia is a genetic test that allows the detection of changes in genes associated with infertility in both women and men. The male panel includes the analysis of 40 genes and the evaluation of sex chromosomes X and Y, including Y chromosome microdeletion. The female panel analyzes the full coding sequence of 55 genes and evaluates sex chromosome aneuploidies, including changes in number, structural changes, and mosaicism.

Rodinia is a genetic test that detects changes in genes associated with male infertility. The panel includes 40 genes and detects abnormalities in sex chromosomes (X and Y), including Y chromosome microdeletions.

Rodinia is a genetic test that detects changes in genes associated with male infertility. The panel includes 40 genes and detects abnormalities of the sex chromosomes (X and Y), including Y chromosome microdeletions.

Rodinia is a genetic test that detects changes in genes associated with female infertility. The panel analyzes the complete coding sequences of 55 genes and assesses sex chromosome aneuploidies, including changes in number, structural alterations, and mosaic variants.

Adventia is a state-of-the-art genetic screening test that can determine whether a person without symptoms is a carrier of a genetic disease. The genetic information provided by Adventia can help you make informed family planning decisions, reducing the risk of passing a genetic disease to your offspring. Adventia, a comprehensive panel, is a study that includes 231 genes associated with diseases with an autosomal recessive and X-chromosome-coupled inheritance model.